Schedule 13G ownership disclosure

Cumberland Pharmaceuticals, Inc.

Common stock · CUSIP: 230770109

Event date: 2026-01-30

Filing-level shares
5,789,155.00
Percent of class
38.4%
  • A.J. Kazimi

    Shares: 5,789,155.00 · Class: 38.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001075050-26-000006
Form type
SCHEDULE 13G
Filer
CUMBERLAND PHARMACEUTICALS INC
CIK
CIK 1087294
Filed
Feb 09, 2026
Reporting period
Jan 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub